Graves’ Disease in Childhood
and Pregnancy
Patients with Graves’ disease have special concerns during pregnancy. For this reason, many doctors in the past have recommended that their patients have radioiodine ablation or surgery before becoming pregnant. With recent knowledge into the autoimmune nature of GD, it appears that this may not necessarily be the best solution for fetal health.
Patients who have become euthyroid or hypothyroid after these treatments are likely to still have high levels of thyroid antibodies, whereas patients who are treated with antithyroid drugs generally experience a significant reduction in their levels of thyroid antibodies.
These antibodies may cross the placental membrane causing transient hyperthyroidism or hypothyroidism in the fetus, depending on the type of antibody present. In patients who are considered “cured” fetal thyroid status is seldom assessed. Endocrinologists familiar with this problem recommend that these patients, especially those who have been treated with radioiodine in the past, have their thyroid antibody titers checked. They also recommend that the fetus be monitored for signs of thyroid dysfunction or goiter.
One type of thyroid antibody, the thyroid peroxidase (TPO) antibody is associated with spontaneous abortion or miscarriage.
Continued in right column...